| # | Title | Journal | Year | Citations |
|---|
| 1 | Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours | Journal of Pathology | 2014 | 1,151 |
| 2 | Cancer classification using the Immunoscore: a worldwide task force | Journal of Translational Medicine | 2012 | 676 |
| 3 | Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer | Cancer | 2011 | 624 |
| 4 | The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: A systematic review of the literature | Cancer Treatment Reviews | 2016 | 432 |
| 5 | Survival comparison between glioblastoma multiforme and other incurable cancers | Journal of Clinical Neuroscience | 2010 | 145 |
| 6 | 5-FLUOROURACIL: A PHARMACOLOGICAL PARADIGM IN THE USE OF CYTOTOXICS | Clinical and Experimental Pharmacology and Physiology | 1998 | 113 |
| 7 | Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors | Annals of Oncology | 2019 | 113 |
| 8 | Anticancer Agents and Cardiotoxicity | Seminars in Oncology | 2006 | 109 |
| 9 | Hypocalcaemia in patients with metastatic bone disease treated with denosumab | European Journal of Cancer | 2015 | 106 |
| 10 | First in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastoma | Journal of Clinical Neuroscience | 2015 | 88 |
| 11 | Radiotherapy in the management of solitary extramedullary plasmacytoma | Internal Medicine Journal | 2005 | 87 |
| 12 | Phase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy | Journal of Clinical Neuroscience | 2011 | 85 |
| 13 | A systematic review on the safety and efficacy of yttrium-90 radioembolization for unresectable, chemorefractory colorectal cancer liver metastases | Journal of Cancer Research and Clinical Oncology | 2014 | 85 |
| 14 | Comparative study of doxorubicin, mitoxantrone, and epirubicin in combination with ICRF-187 (ADR-529) in a chronic cardiotoxicity animal model | Cancer Research | 1992 | 84 |
| 15 | Impact of clinical and molecular features on risk of recurrence following curative intent resection of metastases in metastatic colorectal cancer. | Journal of Clinical Oncology | 2017 | 67 |
| 16 | Bevacizumab and glioblastoma: Scientific review, newly reported updates, and ongoing controversies | Cancer | 2015 | 62 |
| 17 | Analysis of local chronic inflammatory cell infiltrate combined with systemic inflammation improves prognostication in stage II colon cancer independent of standard clinicopathologic criteria | International Journal of Cancer | 2016 | 56 |
| 18 | Optimizing the Outcome for Patients With Rectal Cancer | Diseases of the Colon and Rectum | 2003 | 50 |
| 19 | Imaging modalities in high-grade gliomas: Pseudoprogression, recurrence, or necrosis? | Journal of Clinical Neuroscience | 2012 | 49 |
| 20 | Nivolumab in patients with DNA mismatch repair deficient/microsatellite instability high metastatic colorectal cancer: Update from CheckMate 142. | Journal of Clinical Oncology | 2017 | 49 |
| 21 | Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer | British Journal of Cancer | 2010 | 48 |
| 22 | Squamous Cell Carcinoma Arising in a Giant Condyloma Acuminatum (Buschke-Lowenstein Tumour) | Asian Journal of Surgery | 2005 | 47 |
| 23 | Clinical trial participation and outcome for patients with glioblastoma: Multivariate analysis from a comprehensive dataset | Journal of Clinical Neuroscience | 2013 | 46 |
| 24 | Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17 | Annals of Oncology | 2013 | 44 |
| 25 | A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylatedMGMTglioblastoma: the VERTU study | Neuro-Oncology | 2021 | 44 |
| 26 | Differences of Opinion | Chest | 2004 | 42 |
| 27 | Differentiation of tumor recurrence from radiation necrosis in high-grade gliomas using 201Tl-SPECT | Journal of Clinical Neuroscience | 2008 | 42 |
| 28 | Patient Age and Comorbidity Are Major Determinants of Adjuvant Chemotherapy Use for Stage III Colon Cancer in Routine Clinical Practice | Journal of Clinical Oncology | 2008 | 38 |
| 29 | Awareness of psychological and relationship problems amongst brain tumour patients and its association with carer distress | Psycho-Oncology | 2013 | 36 |
| 30 | Complete radiological and metabolic response of metastatic renal cell carcinoma to SU5416 (semaxanib) in a patient with probable von Hippel-Lindau syndrome | Urologic Oncology: Seminars and Original Investigations | 2004 | 35 |
| 31 | Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) | Annals of Oncology | 2014 | 31 |
| 32 | Human leukocyte antigens: An update on structure, function and nomenclature | Pathology | 1987 | 31 |
| 33 | Therapy of Primary Diffuse Large Cell Lymphoma of the Penis with Preservation of Function | Journal of Urology | 1988 | 29 |
| 34 | A qualitative assessment of the experience of participating in a cancer-related clinical trial | Supportive Care in Cancer | 2011 | 29 |
| 35 | What to do for prostate cancer patients with a rising PSA?—a survey of Australian practice | International Journal of Radiation Oncology Biology Physics | 2003 | 27 |
| 36 | Undertreatment of Elderly Patients with Non–Small-Cell Lung Cancer | Clinical Lung Cancer | 2005 | 26 |
| 37 | Predictors of the use of complementary and alternative medicine (CAM) by women at high risk for breast cancer | European Journal of Cancer | 2009 | 26 |
| 38 | Comparison between poor and long‐term survivors with glioblastoma: Review of an Australian dataset | Asia-Pacific Journal of Clinical Oncology | 2014 | 26 |
| 39 | e-TC: Development and pilot testing of a web-based intervention to reduce anxiety and depression in survivors of testicular cancer | European Journal of Cancer Care | 2017 | 25 |
| 40 | Ribociclib (LEE011) and letrozole in estrogen receptor-positive (ER+), HER2-negative (HER2–) advanced breast cancer (aBC): Phase Ib safety, preliminary efficacy and molecular analysis. | Journal of Clinical Oncology | 2016 | 25 |
| 41 | Survival impact of the Australian National Bowel Cancer Screening Programme | Internal Medicine Journal | 2016 | 22 |
| 42 | Reversal of a neurologic paraneoplastic syndrome with octreotide (sandostatin) in a patient with glucagonoma | American Journal of Medicine | 1991 | 21 |
| 43 | Carcinoma of the anal canal: a local experience and review of the literature | ANZ Journal of Surgery | 2004 | 20 |
| 44 | Communication in and clinician satisfaction with multidisciplinary team meetings in neuro-oncology | Journal of Clinical Neuroscience | 2010 | 20 |
| 45 | Recurrence in patients with stage I colorectal cancer | ANZ Journal of Surgery | 2016 | 20 |
| 46 | Managing cardiotoxicity in anthracycline-treated breast cancers | Expert Opinion on Drug Safety | 2007 | 19 |
| 47 | Overview of biomarkers in metastatic colorectal cancer: Tumour, blood and patient-related factors | Critical Reviews in Oncology/Hematology | 2013 | 19 |
| 48 | Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial | Annals of Oncology | 2019 | 19 |
| 49 | Treatment and outcomes of metastatic colorectal cancer in Australia: defining differences between public and private practice | Internal Medicine Journal | 2015 | 18 |
| 50 | Docetaxel in very elderly men with metastatic castration-resistant prostate cancer | Prostate International | 2015 | 18 |
